255 results found.
BARE BONES® - May 17, 2013
Globus Medical filed a suit against DePuy Synthes, alleging willful infringment of U.S. Patent No. 8,328,872 with the Zero-P VA intervertebral fusion implant. (
BARE BONES® - May 10, 2013
Globus Medical commenced launch of the FORTIFY® I expandable corpectomy spacer, featuring integrated screws for further stability in addition to supplemental fixation. The de...
BARE BONES® - May 2, 2013
Globus Medical reported 1Q13 sales of US $105MM, +10.9% from 1Q12. (U.S. +9.4%, ex-U.S. +30%) (
1Q13 Revenue: Globus Medical
$105MM, +11% (U.S. $96.3MM, +9%; ex-U.S. $8.7MM, +30%) Innovative Fusion $61.3MM, -0.3% Disruptive Technologies $43.7MM, +29% Algea Therapies $1MM   Have attracted several high-quality sales reps from lar...
BARE BONES® - February 27, 2013
Globus Medical posted 4Q12 sales of US $100.5MM, +14% from 4Q11, and 2012 sales of $386.0MM, +16% vs. 2011. (
4Q12 and 2012 Revenue: Globus Medical
$386.0MM, +16% (U.S. $355.6MM, +14%; ex-U.S. $30.4MM, +49%) Fusion $238.7MM, +6% Disruptive Technology $147.3MM, +38% 4Q12 revenue: $100.5MM, +14% (U.S. $91.9MM, +13%; ex-U.S. $8.6MM, +37%) Fusion $58.2MM, +3%
BARE BONES® - January 15, 2013
Globus Medical reported preliminary 4Q12 sales of US $100.5MM, +14% from 4Q11, and 2012 preliminary sales of $386.0MM, +16% from 2011. (
Funding and Start-up Activity in Orthopaedics and Spine: 2012
Start-ups and spin-outs identified during 2012 include:   Accel Spine Dallas, Texas  USA www.accelspine.com • Received 8 orthopaedic-related 51...
Notable Product Launches from 2012
  The following products represent select devices and technologies launched during 2012 across a span of segments.    ARTHROSCOPY/SOFT TISSUE   Covidien: AS Meniscal Repair Device, de...
3Q12 Earnings: Globus Medical
Globus Medical $94.8MM, +13% (U.S. $87.1MM, +11%; Ex-U.S. $7.6MM, +38%) Fusion $57.8MM, +4% Disruptive Technologies $36.9MM, +30%   Overall growth attributed to territory expansion U.S. and ex-U.S., greate...
BARE BONES® - November 1, 2012
Globus Medical posted 3Q12 sales of US $94.8MM, +13% from 3Q11. (Ex-U.S. +38%) (Globus Medical, Inc., 11/1/12)
BARE BONES® - September 28, 2012
Globus Medical received Premarket Approval for the SECURE®-C Cervical Artificial Disc. Clinical data from a 380-patient Investigational Device Exemption study demonstrate that the device is
Final 2Q12 Results
ORTHOWORLD’s estimates place 2Q12 market growth at 5% over 2Q11, as shown in Exhibit 1. Performance highlights follow and pertain to 2Q12, unless otherwise noted.  Exhibit 1 Ort...
BARE BONES® - August 22, 2012
Globus Medical reported 2Q12 sales of US $96.0MM, +19% from 2Q11. (Ex-U.S. +38%) (Globus Medical...
BARE BONES® - August 3, 2012
Globus Medical announced the pricing of its initial public offering of 8.3MM shares of Class A common stock at $12/share (~2MM offered by Globus and ~6.2MM by selling stockholders). Closing of the offering is ...
BARE BONES® - August 2, 2012
Globus Medical lowered the proposed size for its upcoming initial public offering. The company now plans to raise US $104MM by offering 8.3MM shares at a range of $12-$13/share, down from
BARE BONES® - July 18, 2012
Globus Medical plans to raise ~US $200MM in its initial public offering, selling 11.76MM shares at $16-$18 each. (
Final 1Q12 Results
ORTHOWORLD’s estimates place overall 1Q12 market growth at 4% over 1Q11, as shown in Exhibit 1. Performance highlights follow and pertain to 1Q12, unless noted otherwise. Exhibit 1 Orthopaedic Sales1 Increas...
BARE BONES® - May 30, 2012
Globus Medical increased to US $150MM the maximum amount it seeks to raise through an initial public stock offering. (See BARE BONES®,
BARE BONES® - May 29, 2012
Globus Medical reported 1Q12 sales of US $94.7MM, +21% from 1Q11. (Form S/1-A for Globus Medical, Inc., SEC.gov, 5/29/12)
Funding Activity in Orthopaedics and Spine
Start-ups and spin-outs identified during 1Q12 include: Apto Orthopaedics Akron, Ohio  USA Formed by Austen BioInnovation Institute 1st device will address treatment of pediatric spinal deformities
BARE BONES® - March 29, 2012
Globus Medical filed to raise up to US $100MM in an initial public offering of common stock. The company, which posted 2011 sales of $331.5MM, intends to list on the New York Stock Exchange under the symbol
BARE BONES® - February 29, 2012
FDA reached a civil money penalty settlement with Globus Medical regarding distribution of NuBone Osteoinductive Bone Graft without proper premarket approval or clearance. Globus will ...
Companies Receiving First Orthopaedic-related 510(k) Clearances in 2011
For complete information  on these strategic 510(k) filings, please visit FDA’s 510(k) Premarket Notification Database online at www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm. ...
Noted at the North American Spine Society Annual Meeting
As in 2010, this year’s North American Spine Society (NASS) meeting reflected the impact of macro pressures in spine. The following summary echoes sentiments from the voices of surgeons, and offers a look at the pertinent conference takeaways. Highlights of specific company intelligence ...
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2020 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group